BioImagene Extends TissueMine™ 1.8 Collaboration With Oracle

BioImagene today announced that TissueMine™ 1.8 -- a total digital pathology solution for research and development, will support Oracle® Database 10g and Oracle interMedia -- which enables the efficient management and retrieval of image and other data within an Oracle Database.

TissueMine™ is a fully integrated, ready to use package with digital image acquisition, objective analysis, efficient image management, image mining and reporting. It includes iScan™ -- BioImagene’s new tissue slide scanner, high performance server, storage systems, high resolution display terminal and a comprehensive software application. TissueMine™ is 21 CFR Part 11 and GLP compliant.

BioImagene is a member of the Oracle PartnerNetwork and can offer users a cost-effective digital pathology solution on a proven platform by working with Oracle. Steven Hagan, Oracle Vice President, Server Technologies, said, “We are pleased to work with BioImagene to bring Oracle’s secure, reliable database to the Life Sciences market as part of a complete solution that extracts knowledge from tissue images. The sophisticated storage, data mining and archival capabilities provided by Oracle® Database 10g with Oracle interMedia enables virtually seamless information flow to researchers.”

Dr. Bruce Williams MD, Armed Forces Institute of Pathology (AFIP), a TissueMine™ user, said, “We have found TissueMine™ functionalities like automatic identification of region of interest, whole slide analysis, road map image view, morphology and intensity based analysis to be a valuable tool for our scientists. As a concomitant Oracle user, we anticipate BioImagene’s support of Oracle® Database 10g and Oracle interMedia to be a step forward in the digitization of pathology that will help further improve accuracy and consistency in the study of tissue samples.”

Mohan Uttarwar, BioImagene CEO, said, “We are very excited to work with Oracle to deliver superior solutions for our customers. This combined offering can significantly reduce the cycle time for R&D studies. It pairs Oracle’s world renowned database capabilities and our software imaging application strengths.”